Why the study?
Does troponin elevation or myocardial ischemia predict survival in high-cardiac-risk intensive care unit patients?
Does troponin elevation or myocardial ischemia predict survival in high-cardiac-risk intensive care unit patients?
In high-cardiac-risk ICU patients, silent ischemia is associated with troponin elevation, and troponin elevation (but not ischemia) strongly predicts early and late mortality.
Troponin elevation may identify high-mortality-risk ICU patients; leaves open whether ischemia adds independent prognostic value.
OBJECTIVES: To determine the incidence and association of myocardial ischemia with troponin elevation and survival in high-cardiac-risk intensive care patients. DESIGN: Prospective observational study. SETTING: Intensive care unit of a tertiary hospital. SUBJECTS: One-hundred one general intensive care unit patients having a history of coronary artery disease or at least two risk factors for coronary artery disease. INTERVENTIONS: Continuous 12-lead electrocardiographic monitoring with on-line ST-trend analysis, daily cardiac troponin measurements, clinical and physiologic assessment, and up to 2-yr follow-up for survival. MEASUREMENTS AND MAIN RESULTS: During 8,988 hrs or a mean +/- sd of 95 +/- 85 hrs/patient of continuous 12-lead electrocardiographic monitoring, 21 patients (21%) had ischemic ST-segment changes, characterized in most (19) by ST depression and lasting >60 mins in 15 (71.4%). Of the 38 patients (38%) with troponin elevation, myocardial infarction was clinically suspected in four and myocardial ischemia on continuous 12-lead electrocardiographic monitoring was observed in 14 (36.8%). Fourteen (66.7%) of the patients with ischemic ST changes and 12 (75%) of those with prolonged (>60 mins) ischemia had troponin elevation. The sensitivity, specificity, and positive and negative predictive values of prolonged (>60 mins) ischemia predicting troponin elevation were 31.6%, 95.2%, 80.0%, and 69.8%, respectively. Prolonged (>60 mins) ischemia was significantly associated with troponin elevation by both univariate and multivariate analyses (odds ratio = 9.0; p = .008). Acute Physiology and Chronic Health Evaluation II score, renal failure, and the use of norepinephrine also independently predicted troponin elevation. Troponin but not ischemia predicted increased 1-month, 6-month, and 2-yr mortality (odds ratio = 6.0, 3.2, and 2.99, respectively; p < .001). CONCLUSIONS: Silent ischemia is strongly associated with troponin elevation in high-cardiac-risk intensive care unit patients, and troponin elevation predicts both early and late mortality.
No takes yet. Share an insight, caveat, or question.
Landesberg et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: